Adamas Pharmaceuticals (United States)

Recent papers from Adamas Pharmaceuticals (United States)

1. Abstract 3099: Selective CDK2 inhibition with ECI830: preclinical characterization, efficacy, and on-target mechanism supported by biomarker and gene signature analysisCancer Research · 2026
2. Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single‐Dose Phase 1 StudyClinical Pharmacology in Drug Development · 2026
3. Treatment patterns in advanced gastric cancer (GC) across racial and ethnic groups in the immunotherapy era: A retrospective claims data analysis in the United States.Journal of Clinical Oncology · 2026
4. Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement riskNature Communications · 2025
5. Functional NK engagers from OmniClic, a common light-chain platform producing fully human-sequence antibodies in a chicken host speciesmAbs · 2025
6. Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-upAdvances in Therapy · 2025
7. Beyond the Limits: How Is Spectral Flow Cytometry Reshaping the Clinical Landscape and What Is Coming Next?Cells · 2025
8. Interest in period pills in the United States: A nationally representative survey, 2021–2022Contraception · 2025
9. Experimental Conditions to Retrieve Intrinsic Cooperativity α Directly from Single Binding Assay Data Exemplified by the Ternary Complex Formation of FKBP12, MAPRE1 and Macrocyclic Molecular GluesInternational Journal of Molecular Sciences · 2025
10. Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discoverymAbs · 2024
11. Rational Design of Enhanced Nme2Cas9 and Nme2 Smu Cas9 Nucleases and Base Editors2024
12. Sustainable production of 2,3,5,6-Tetramethylpyrazine at high titer in engineered Corynebacterium glutamicumJournal of Industrial Microbiology & Biotechnology · 2024
13. Association between relative age at school and persistence of ADHD in prospective studies: an individual participant data meta-analysisThe Lancet Psychiatry · 2023
14. Noncanonical Activity of Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Improves Cognition and Synapse Density in AgingeNeuro · 2023
15. Three‐Dimensional Steady‐State Hydraulic Tomography Analysis With Integration of Cross‐Hole Flowmeter Data at a Highly Heterogeneous SiteWater Resources Research · 2023
16. The Effects of Virtual Reality Telemedicine With Pediatric Patients Diagnosed With Posttraumatic Stress Disorder: Exploratory Research Method Case ReportJMIR Formative Research · 2023
17. A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites2023
18. Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaFrontiers in Neurology · 2022
19. Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson’s diseasenpj Parkinson s Disease · 2022
20. ACCELERATE – Five years accelerating cancer drug development for children and adolescentsEuropean Journal of Cancer · 2022